Scientists from The University of Texas at Arlington and the University of North Texas Health Science Center are building a prototype for an implantable in-line shunt flow monitoring system that would ...

Heart failure with preserved ejection fraction (HFpEF) can arise from a range of genetic and physiological triggers, but the common denominator—elevated left atrial (LA) pressure—has spawned a host of ...

Funding to support next stage of product development and early clinical experience of company's novel interatrial shunt and remote monitoring solution for patients with heart failure Adona Medical is ...

Medical device tech company Rhaeos said in a press release that it has been awarded a $1.5 million grant from the National Institute of Neurological Disorders & Stroke, part of the National Institutes ...

BOSTON, MA—One-year outcomes from an early feasibility study (EFS) show durable improvements in symptoms and quality of life in symptomatic heart failure (HF) patients treated with a novel coronary ...

Madison Scientific, also known as MadSci, announced it secured an additional $3 million in seed funding, adding to its $7 million financing round co-led by WARF Ventures and two other investors, ...

For permission requests, please contact NEJM Reprints at [email protected] The shunt equation may be expressed as follows 9: where Q = total cardiac output in liters per minute; Qs = shunt flow in ...

Hydrocephalus involves the buildup of excess fluid in the brain. It affects more than 1 million people in the U.S. – most of them children – and can result in brain damage and related neurological ...

A ventriculoperitoneal (VP) shunt is a medical device that relieves pressure on the brain caused by the accumulation of fluid. Ventriculoperitoneal (VP) shunts are primarily used to treat a condition ...

Oct. 21, 2002 — Low-flow cerebroventricular shunting may be worth investigating further in Alzheimer's disease, according to the authors of a pilot study reported in the Oct. 22 issue of Neurology.

Paul G. Donohue M.D. DEAR DR. DONOHUE: I am writing this for my husband. About five years ago, he was diagnosed with hemochromatosis. The iron damaged his liver and pancreas. He is not a candidate for ...